Vishwa J. Amatya
Hiroshima, 7348551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.
Journal: Journal of neuro-oncology
Published: February 15, 2026
Rasmussen encephalitis without atrophy and increased 11C-methionine PET uptake mimicking glioma: A case report.
Journal: The neuroradiology journal
Published: December 20, 2025
Cortical Diffusion-Enhancement Mismatch Sign: A Specific Imaging Biomarker for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma.
Journal: Neurosurgery
Published: October 24, 2025
Merlin Immunohistochemistry Is Useful in the Differential Diagnosis of Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia.
Journal: Pathology international
Published: October 07, 2025
Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.
Journal: Japanese journal of clinical oncology
Published: July 16, 2025
Differences in clinical course between pituitary apoplexy and non-apoplexy patients with nonfunctioning pituitary neuroendocrine tumors.
Journal: Neurosurgical review
Published: June 26, 2025
Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.
Journal: Journal of neuro-oncology
Published: October 31, 2024
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.
Journal: Journal of neuro-oncology
Published: May 06, 2024
Reply to "Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma" by Churg et al.
Journal: The American journal of surgical pathology
Published: February 15, 2024
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant.
Journal: Neurosurgical review
Published: December 23, 2023
Characteristics of radiation-induced brain tumors: case series and systematic review.
Journal: Journal of neurosurgery
Published: December 21, 2023
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.
Journal: Journal of neuro-oncology
Published: December 19, 2023
Last Updated: 09/26/2026